Collectively, these results suggest that rVP1 modulates integrin β1/Akt signaling to downregulate COX-2/PGE2 that then attenuates MIG-7 protein level resulting in inhibition of the EMT, MMP-2 activity and invasion of lung cancer cells. The gene discussed is MMP2; the disease is lung carcinoma.